๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for CML (Chronic Myelogenous Leukemia)

ELVN-001 for the Treatment of Chronic Myeloid Leukemia With and Without T315I Mutation in Japanese Participants NCT06787144Phase 14 sites๐Ÿ“ Akita๐Ÿ“ Sapporo๐Ÿ“ Suita-shi Enliven Therapeutics ยท Tests: ELVN-001 A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias NCT06994676Phase 111 sites๐Ÿ“ Duarte๐Ÿ“ Palo Alto๐Ÿ“ Tampa Crossbow Therapeutics, Inc. ยท Tests: CBX-250 International Chronic Myeloid Leukemia Pediatric Study NCT01281735n/a20 sites๐Ÿ“ North Adelaide๐Ÿ“ Vienna๐Ÿ“ Minsk Poitiers University Hospital TGRX-678 US Phase I for Chronic Myelogenous Leukemia Patients NCT06088888Phase 12 sites๐Ÿ“ Houston๐Ÿ“ Seattle Shenzhen TargetRx Co., Ltd. ยท Tests: TGRX-678 Sorafenib Relapase Prophylaxis After HCT With PTBCy Regimen NCT06532084Phase 21 site๐Ÿ“ Saint Petersburg St. Petersburg State Pavlov Medical University ยท Tests: Sorafenib Real-world Study of Scemblix in the Treatment of Chronic Myeloid Leukemia in China NCT07375355n/a1 site๐Ÿ“ Wuhan Novartis Pharmaceuticals Impact of Targeted Therapy on Cancer-Related Cognitive Impairment NCT07638007n/a1 site๐Ÿ“ Rochester University of Rochester NCORP Research Base A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) NCT01351545n/a142 sites๐Ÿ“ Birmingham๐Ÿ“ Gilbert๐Ÿ“ Phoenix Center for International Blood and Marrow Transplant Researโ€ฆ ยท Tests: A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) Optimization of Post-transplantation Benadamustine and Cyclophosphamide in Patients With High-risk Myeloid Malignancies and a Partially Mismatched Donor NCT07238712Phase 21 site๐Ÿ“ Saint Petersburg St. Petersburg State Pavlov Medical University ยท Tests: Ruxolitinib, Abatacept (Orencia) A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy NCT07091019n/a17 sites๐Ÿ“ Birmingham๐Ÿ“ Stockton๐Ÿ“ Torrance Novartis Pharmaceuticals ยท Tests: TKIs Olverembatinib Combined With Venetoclax and Azacitidine in Blast Phase Ph Chromosome-positive CML NCT06757855Phase 1, Phase 21 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: Olverembatinib, Venetoclax, Azacitidine A Study on the Tolerability, Safety and Effectiveness of Asciminib in Patients With Philadelphia Chromosome-positive Chronic Myeloid Leukemia in the Chronic Phase in Germany NCT07549516n/a69 sites๐Ÿ“ Baden-Baden๐Ÿ“ Heidenheim๐Ÿ“ Schwรคbisch Hall Novartis Pharmaceuticals Phase II Study of Asciminib for Second-line Treatment of Chronic Phase Chronic Myeloid Leukemia NCT06629584Phase 21 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Asciminib Efficacy and Safety of Generic Imatinib (Carcemiaยฎ) Compared to Glivecยฎ in Real-Life Management of Chronic Phase of Chronic Myeloid Leukemia NCT05282108n/a4 sites๐Ÿ“ Cairo๐Ÿ“ Cairo๐Ÿ“ Cairo Hikma Pharmaceuticals LLC ยท Tests: Carcemia, Glivec Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer NCT01137643n/a1 site๐Ÿ“ Chapel Hill UNC Lineberger Comprehensive Cancer Center ยท Tests: biologic sample preservation procedure, cytology specimen collection procedure CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant NCT06059391Phase 23 sites๐Ÿ“ Duarte๐Ÿ“ Atlanta๐Ÿ“ Boston City of Hope Medical Center ยท Tests: Allogeneic Hematopoietic Stem Cell Transplantation, Biospecimen Collection, Granulocyte Colony-Stimulating Factor, Hemaโ€ฆ Study of Olverembatinib (HQP1351) in Patients With CML-CP NCT06423911Phase 3163 sites๐Ÿ“ Birmingham๐Ÿ“ Anchorage๐Ÿ“ Goodyear Ascentage Pharma Group Inc. ยท Tests: olverembatinib, Bosutinib Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL NCT04260022Phase 19 sites๐Ÿ“ Birmingham๐Ÿ“ Duarte๐Ÿ“ Atlanta Ascentage Pharma Group Inc. ยท Tests: Ascentage Pharma HQP1351 bioavailable inhibitor, Blinatumomab Asciminib RMP Study NCT05943522n/a17 sites๐Ÿ“ Wลnju๐Ÿ“ Anyang-si๐Ÿ“ Bucheon-si Novartis Pharmaceuticals ยท Tests: Asciminib Second STOP After Pioglitazone Priming in CML Patients NCT02889003Phase 26 sites๐Ÿ“ Le Chesnay๐Ÿ“ Le Kremlin-Bicรชtre๐Ÿ“ Lyon Versailles Hospital ยท Tests: Pioglitazone + TKI A Potential Relationship Between Treatment With Tyrosine Kinase Inhibitors and Erectile Dysfunction in Male Patients With Chronic Myeloid Leukemia NCT07061145n/a1 site๐Ÿ“ Reggio Emilia Azienda USL Reggio Emilia - IRCCS ยท Tests: Tirosin Kinase Inhibitors Personalized NK Cell Therapy in CBT NCT02727803Phase 21 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Allogeneic Natural Killer Cell Line NK-92, Anti-Thymocyte Globulin, Busulfan, Clofarabine, Cyclophosphamide A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant NCT07020533Phase 13 sites๐Ÿ“ Duarte๐Ÿ“ Atlanta๐Ÿ“ Boston City of Hope Medical Center ยท Tests: Biospecimen Collection, Electronic Health Record Review, Haploidentical Hematopoietic Cell Transplantation, Letermovir,โ€ฆ Allo HSCT Using RIC and PTCy for Hematological Diseases NCT05805605Phase 21 site๐Ÿ“ Minneapolis Masonic Cancer Center, University of Minnesota ยท Tests: Peripheral Blood Stem Cell Transplant, Allopurinol 300 MG, Fludarabine, Cyclophosphamide, Bone Marrow Cell Transplant Interaction Between Gut Microbiota and TKIs in Defining the Clinical Outcomes of Patients With CML NCT06724536n/a1 site๐Ÿ“ Torino Carmen Fava ยท Tests: non interventional study with the use of biological samples. Quality of Life and Care Organization of Patients With Chronic Myeloid Leukemia in the Lombardy Hematology Network NCT07165535n/a1 site๐Ÿ“ Monza University of Milano Bicocca The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen NCT01890486n/a1 site๐Ÿ“ Winston-Salem Wake Forest University Health Sciences Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution NCT06131801n/a6 sites๐Ÿ“ Aurora๐Ÿ“ Atlanta๐Ÿ“ Cincinnati Children's Hospital Medical Center, Cincinnati ยท Tests: 1. Drug: The Venetoclax PK study is collecting bodily fluid samples (ie., whole blood and optional cerebrospinal fluid)โ€ฆ Therapeutic RSK1 Targeting in Myeloid Malignancies NCT07379125Phase 11 site๐Ÿ“ St Louis Washington University School of Medicine ยท Tests: PMD-026 Safety and Tolerability of ZE74-0282 in Healthy Volunteers NCT07527221Phase 11 site๐Ÿ“ Randwick Eilean Therapeutics AU Pty Ltd ยท Tests: ZE74-0282-0001 or placebo
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy